Source material from University of Florida Cell Biology
Tags: ground substance, GAGs, glycosaminoglycans, proteoglycans, hyaluronan, mucopolysaccharidoses, MPS, Hurler syndrome, Hunter syndrome, lysosomal storage disease, immune surveillance, inflammatory response, histamine, cytokines, chemokines, wound healing, inflammation, granulation tissue, neoangiogenesis, re-epithelialisation, tissue remodelling
Difficulty: Intermediate Prerequisites: Parts 1 and 2 of these notes (CT structure, ECM, cell types, collagen, elastic fibres).
The ECM is not just fibres. The gel-like ground substance between those fibres resists compression, organises water, and controls the diffusion of nutrients and signalling molecules. When the enzymes that break down ground substance components are missing, the result is a group of inherited storage diseases called mucopolysaccharidoses. Meanwhile, connective tissue is also the arena for immune surveillance and the entire wound healing cascade, from the initial inflammatory flare to final tissue remodelling months later. This section pulls together the "soft" side of the ECM with the immune and repair functions of CT.
Ground substance (GAGs, proteoglycans, MAGs) fills the space between fibres and cells, resists compression, and facilitates molecular transport. Inherited deficiencies in GAG-degrading enzymes cause mucopolysaccharidoses (Hurler, Hunter, and others). Connective tissue houses both resident and transient immune cells that mount inflammatory responses. Wound healing proceeds through four overlapping phases: inflammation, granulation, re-epithelialisation, and remodelling.
Ground substance
The gel-like, non-fibrous part of the ECM, composed of GAGs, proteoglycans, and multiadhesive glycoproteins. Think of it as the hydrated filler that cushions cells and controls what can diffuse through the tissue.
Glycosaminoglycans (GAGs)
Long, unbranched polysaccharide chains that are negatively charged and attract water. Examples: hyaluronan, chondroitin sulphate, keratan sulphate, heparan sulphate. In simple terms, GAGs are molecular sponges.
Hyaluronan (hyaluronic acid)
The only GAG that is not sulphated and not attached to a core protein. It forms enormous hydrated aggregates and is a major component of synovial fluid and the vitreous humour of the eye.
Proteoglycan
A core protein with many covalently attached GAG chains, forming a bottle-brush structure. Aggrecan in cartilage is the most commonly cited example. In simple terms, proteoglycans are the molecular scaffolds that hold GAGs in place and organise water.
Multiadhesive glycoproteins (MAGs)
Proteins such as fibronectin and laminin that link cells to the ECM by binding both cell-surface receptors (integrins) and ECM molecules (collagen, GAGs).
Mucopolysaccharidoses (MPS)
A group of inherited lysosomal storage diseases caused by deficiencies in enzymes that degrade GAGs. GAGs accumulate in lysosomes, impairing cell function.
Hurler syndrome (MPS I)
Caused by deficiency of alpha-L-iduronidase. The most severe form of MPS I. Features include coarse facial features, skeletal deformities, organomegaly, corneal clouding, and developmental delay.
Hunter syndrome (MPS II)
Caused by deficiency of iduronate-2-sulphatase. X-linked recessive, so it occurs almost exclusively in males. Similar features to Hurler syndrome but typically without corneal clouding.
Histamine
A vasoactive amine released by mast cells and basophils that causes vasodilation and increased vascular permeability. In simple terms, histamine opens blood vessels wider and makes them leakier, which is why inflamed tissue swells and reddens.
Cytokines
Signalling proteins released by immune cells (and other cells) that recruit, activate, and regulate other immune cells. Think of them as the chemical messages of the immune system.
Chemokines
A subset of cytokines that specifically guide the migration of immune cells towards the site of infection or injury, creating a chemical gradient the cells follow.
Granulation tissue
The new, vascularised tissue that forms during wound healing, composed of proliferating fibroblasts, new capillaries, and fresh ECM. It has a granular appearance under the microscope due to the many small new blood vessels.
Tissue remodelling
The final phase of wound healing, during which collagen fibres reorganise along lines of mechanical stress and excess cells, vessels, and ECM are removed. This phase can last months to years.
Ground substance fills the space between fibres and cells. Its three components work together.
GAGs attract and hold water because of their dense negative charges, creating a hydrated gel that resists compression. This is why cartilage can bear weight without collapsing: the water trapped by GAGs pushes back against compressive forces.
Proteoglycans organise GAGs spatially. Aggrecan, the proteoglycan in cartilage, binds to a hyaluronan backbone to form massive aggregates that can hold 50 times their weight in water.
MAGs (fibronectin, laminin) act as bridges, connecting cells to their surrounding matrix. Fibronectin binds collagen on one side and integrins on the cell surface on the other.
The hydrated matrix also facilitates diffusion of nutrients, hormones, and waste products between blood capillaries and tissue cells.
MPS disorders arise when a lysosomal enzyme needed to break down GAGs is absent or deficient.
Pathogenesis
Cells continually take up and degrade GAGs in their lysosomes as part of normal turnover.
If the specific enzyme for a particular GAG is missing, that GAG accumulates inside lysosomes.
Swollen lysosomes disrupt normal cell function, leading to progressive tissue and organ damage.
Clinical features common to most MPS types
Coarse facial features
Skeletal deformities (dysostosis multiplex)
Organomegaly (enlarged liver and spleen)
Developmental delay (in severe forms)
Joint stiffness
Key MPS types
Hurler syndrome (MPS I-H): deficiency of alpha-L-iduronidase. Autosomal recessive. Severe intellectual disability, corneal clouding, death in childhood if untreated.
Hunter syndrome (MPS II): deficiency of iduronate-2-sulphatase. X-linked recessive. Variable severity. Corneal clouding is typically absent, which helps distinguish it from Hurler syndrome on exams.
Several other MPS types exist (Sanfilippo, Morquio, Maroteaux-Lamy, Sly), each affecting a different GAG-degrading enzyme. Introductory courses usually focus on Hurler and Hunter.
Connective tissue is where immune defence plays out. The cells involved were introduced in Part 1; here the focus is on how they work together.
Resident immune cells
Macrophages phagocytose pathogens and present antigens to lymphocytes, bridging innate and adaptive immunity.
Mast cells detect damage or allergens and release histamine and heparin, triggering the inflammatory cascade.
Plasma cells secrete antibodies that tag pathogens for destruction.
Transient immune cells (recruited from blood)
Neutrophils arrive first, phagocytosing bacteria and dying to form pus.
Eosinophils target parasites and modulate allergic inflammation.
Basophils release histamine, amplifying the response.
Lymphocytes (T and B cells) drive adaptive, antigen-specific immunity.
Monocytes enter tissue and differentiate into macrophages to sustain phagocytic activity.
Key inflammatory mediators
Histamine: causes vasodilation and increased vascular permeability, producing the redness, heat, and swelling of inflammation.
Cytokines: recruit and activate immune cells at the injury site.
Chemokines: establish a concentration gradient that guides migrating immune cells to where they are needed.
Wound healing proceeds through four overlapping phases. The sequence is a common exam target.
1. Inflammation
Mast cells in the injured tissue degranulate, releasing histamine and other mediators.
Vasodilation and increased permeability cause oedema (swelling).
Neutrophils are recruited from the blood and phagocytose bacteria and debris.
This phase begins within minutes and lasts several days.
2. Granulation and neoangiogenesis
Fibroblasts proliferate and begin depositing new ECM (initially type III collagen, later replaced by type I).
New capillaries sprout from existing vessels (neoangiogenesis), supplying oxygen and nutrients to the healing tissue.
The result is granulation tissue: a pink, granular, highly vascular new tissue that fills the wound bed.
3. Re-epithelialisation
Epithelial cells at the wound edges migrate across the granulation tissue to re-establish a continuous surface.
Cell division at the wound margins produces new epithelial cells to replace those lost.
4. Tissue remodelling
Type III collagen is gradually replaced by stronger type I collagen.
Collagen fibres reorganise along lines of mechanical stress, increasing tensile strength.
Excess cells, blood vessels, and ECM are removed by apoptosis and matrix metalloproteinases.
This phase can take months to years. Even fully healed wounds typically reach only about 80% of the original tissue's tensile strength.
Enzyme replacement therapy (ERT) is now available for several MPS types, including Hurler and Hunter syndromes. The treatment delivers the missing enzyme intravenously, slowing GAG accumulation, though it does not cross the blood-brain barrier well enough to prevent neurological decline in the severe forms. Understanding wound healing phases is essential for nursing and surgical practice: keeping a wound moist and free of infection supports the granulation phase, while premature mechanical stress during remodelling can weaken the scar.
Students sometimes think ground substance is inert filler. It is biologically active: it regulates cell signalling, controls diffusion, and resists mechanical forces.
MPS disorders are not the same as mucopolysaccharide overproduction. The GAGs are produced at normal rates; the problem is that they cannot be broken down, so they accumulate.
Wound healing phases are taught as a neat sequence, but in reality they overlap considerably. Inflammation does not finish before granulation begins; the phases run concurrently in different parts of the wound.
The scar that forms after wound healing is not identical to the original tissue. It is predominantly type I collagen without the original tissue's organisation, which is why scars are weaker and look different from surrounding skin.
⚠️ Know the three components of ground substance (GAGs, proteoglycans, MAGs) and their functions (resist compression, organise water, link cells to ECM).
⚠️ Hurler vs. Hunter syndrome: both are MPS, but Hurler is autosomal recessive with corneal clouding; Hunter is X-linked recessive without corneal clouding. This is a classic exam distinction.
⚠️ Be able to list the four wound healing phases in order: inflammation, granulation/neoangiogenesis, re-epithelialisation, remodelling.
⚠️ Know which cells dominate which phase: neutrophils in inflammation, fibroblasts in granulation, epithelial cells in re-epithelialisation.
⚠️ The collagen switch during healing (type III early, replaced by type I later) is frequently tested.
True or false: GAGs are positively charged polysaccharides that repel water.
Fill in the blank: Mucopolysaccharidoses are caused by deficiencies in lysosomal enzymes that degrade __________.
True or false: Hunter syndrome is autosomal recessive.
Fill in the blank: The first immune cells to arrive at a wound site are __________.
True or false: During wound remodelling, type III collagen is replaced by type I collagen.
Answers: 1. False (GAGs are negatively charged and attract water). 2. GAGs (glycosaminoglycans). 3. False (Hunter syndrome is X-linked recessive). 4. Neutrophils. 5. True.
Q: What is the function of proteoglycans in the ground substance?
A: Proteoglycans organise GAG chains spatially and help trap water, providing structural support and resistance to compressive forces. Their bottle-brush structure creates a hydrated gel that cushions tissues.
Q: How do mucopolysaccharidoses develop at the cellular level?
A: A lysosomal enzyme required to degrade a specific GAG is absent or deficient. The undegraded GAG accumulates within lysosomes, causing them to swell and impairing normal cell function, which leads to progressive tissue damage.
Q: What distinguishes Hurler syndrome from Hunter syndrome?
A: Hurler syndrome (MPS I) is autosomal recessive, involves alpha-L-iduronidase deficiency, and features corneal clouding. Hunter syndrome (MPS II) is X-linked recessive, involves iduronate-2-sulphatase deficiency, and typically lacks corneal clouding.
Q: Describe the four phases of wound healing and name the key cell type in each.
A: 1) Inflammation: mast cells trigger the response, neutrophils arrive to clear debris. 2) Granulation and neoangiogenesis: fibroblasts proliferate and deposit ECM, new capillaries form. 3) Re-epithelialisation: epithelial cells migrate across the wound surface. 4) Tissue remodelling: fibroblasts and matrix metalloproteinases reorganise and reduce collagen, cells, and vessels over months to years.
Q: Why does a healed wound never regain 100% of the original tissue's strength?
A: The scar is composed of type I collagen that, while strong, lacks the precise fibre organisation of the original tissue. The collagen in a scar is deposited in a somewhat disorganised pattern compared to the native tissue, reaching roughly 80% of original tensile strength.
Ground substance biology connects to joint physiology (synovial fluid is rich in hyaluronan) and to pharmacology (hyaluronidase is used clinically to increase tissue permeability for drug delivery). MPS disorders connect to genetics (inheritance patterns) and to lysosomal biology from earlier cell biology lectures. Wound healing connects back to the collagen synthesis pathway in Part 2 and forward to pathology topics on scarring, fibrosis, and keloid formation.
ground substance, GAGs, glycosaminoglycans, hyaluronan, hyaluronic acid, chondroitin sulphate, keratan sulphate, heparan sulphate, proteoglycans, aggrecan, multiadhesive glycoproteins, MAGs, fibronectin, laminin, integrin, mucopolysaccharidoses, MPS, lysosomal storage disease, Hurler syndrome, MPS I, alpha-L-iduronidase, Hunter syndrome, MPS II, iduronate-2-sulphatase, enzyme replacement therapy, immune surveillance, inflammatory response, macrophage, mast cell, plasma cell, neutrophil, eosinophil, basophil, lymphocyte, monocyte, histamine, cytokines, chemokines, wound healing, inflammation, granulation tissue, neoangiogenesis, re-epithelialisation, tissue remodelling, scar formation, type III collagen, type I collagen, cell biology, histology